Table 2 Clinical use of human cultured epithelial substitutes (CESs).

From: Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries

References

Cells

Type of clinical study

N (male / female)

Age (years)a

Treatment-related adverse events

Indication

Total body surface area (TBSA) affected (%)a

Affected area covered (%)a or Affected area covered (%TBSA)a

TESS successful engraftment (%)a or TESS successful engraftment (% TBSA)a

Period between skin biopsy and grafting (days)a

Follow-up (months)a

Outcomes

41

Autologous epidermal cells

Case Report

2 (2/0)

49.5 ± 16.2 (38–61)

None

Burns

60 ± 28.3 (40–80)

100

14–21

6

Absence of stratum corneum during the first week, but 6 months after grafting, the epidermis could not be distinguished from native skin

42

Autologous keratinocytes

Case Report

17 (11/6)

31.8 ± 14.4 (2–56)

None

Burns

56.1 ± 18.3 (31–85)

31

18–22

1–1.5

In some cases, 80% of epithelialized skin was achieved after 6 weeks. Hypertrophic scar formation was less than observed in comparable areas treated with meshed grafts

43

Autologous keratinocytes

Case Report

26

-

None

Burns

50 (2–75)

15 (0–98)

7

Limited success

44

Autologous keratinocytes

Case Report

26

29.03 ± 18.7 (5–80)

None

Burns

33 ± 16.7 (10–75)

12.5 ± 6.4 (5–35)

32.1 ± 15.3 (0–65)

20–22

6

Keratinocyte culture “take” was significantly lower than that split-thickness skin grafts

4

3.7 ± 1.9 (1–5)

None

Giant congenital nevus

55.9 ± 30.9 (30–100)

56.2 ± 13.7 (40–70)

45

Autologous keratinocytes

Case Report

16

29.7 (10–56)

None

Burns

68.2 (42–85)

15.9 (4–59)

4.7 (0–18.6)

4.3 (1.7–9.2)

No impact on the definitive closure of massive burn wounds

46

Autologous keratinocytes

Case Report

5 (4/1)

38.8 (20–60)

None

Burns

59.6 (48–70)

93.6 (87–100)

48

Only two patients required any additional grafts to cover open wounds that had originally been covered with CESs

47

Autologus epithelial cells

Case Report

28

35.3

None

Burns

52.2

10.4 (2–35)

26.9

60

After 5 years of use, CES engraftment was unpredictable and inconsistent. Should be used only as biologic dressing and experimental adjunct to conventional burn wound coverage with split-thickness autograft

48

Autologous keratinocytes

Observational Study

29

26

None

Burns

77

53

14–18

3

Good cosmetic appearance when compared with meshed split-thickness skin grafting

8

2.8

None

Scald wounds

23

73

49

Autologous keratinocytes

Case Report

7 (4/3)

11.6 ± 10.7 (1.7–30)

None

Burns

45.7 ± 19.88 (20–75)

97.1 ± 7.5

14

2–20

Epidermal regeneration evaluated 1 month after grafting was stable and complete. Epidermis appeared fully differentiated with a well-developed stratum granulosum

50

Autologous keratinocytes

Non-randomized trial

8

10.5 ± 2

Reconstructive procedures were required in the first 2 years for functional problems

Burns

92.5 ± 1.9

44 ± 7

60 ± 8

21

24

After follow-up scars had a significantly smoother surface and less pigmentation than traditional meshed autografts

51

Autologous keratinocytes

Non-randomized controlled trial

7

32.1 ± 18 (9–65)

None

Burns

68.7 ± 20.4 (51–95)

65 ± 46.6

16–22

1

An undulated dermo-epidermal junction was present underneath the grafted epithelia cultured on fibrin gel matrices

52

Autologous epidermal cell sheets

Non-randomized controlled trial

14

40.8 ± 18.3 (3–61)

None

Palmoplantar wounds

100

100

1

27.6 ± 10.5 (12–48)

Expression of keratin 9 was continuously observed after the transplantation

53

Autologous keratinocytes

Non-randomized controlled trial

7

6.4 ± 1.4

None

Burns Reconstructive releases

75.9 ± 5.0

100

12

Successful vascularization was observed in 45.7 ± 14.2% of the wounds, after 14 days

54

Autologous epidermal cells

Case Report

2 (2/0)

33 ± 1.4 (32–34)

None

Burns

75 ± 14.1 (65–85)

0

21–28

0.4

These substitutes could be useful as temporary biological dressing as the take was so poor

55

Allogeneic keratinocytes

Retrospective Observational Study

13 (7/6)

62.2 ± 15.7 (34–84)

None

Chronic skin ulcers

100

100

3.2 ± 2.3 (0.6–7)

There was an overall reduction of 91.5% of wound size in comparison with initial value

56 (NCT00832156)

Autologous epidermal cells

Randomized Controlled Trial (parallel assignment)

40 (25/15)

50 ± 19 (20–85)

None

Burns

24.2 ± 13 (6–51)

90 ± 12.6 (6–51)

13

12

Epithelialization increased in the wounds after 5–7 days (71.2 ± 24.8%)

  1. aExpression of measures: mean ± standard deviation (range).